For our application, I would like to inform you that the application of the chemical is related to our work at SIIPL, which is one of the manufacturers of these aP antigen bulk (PT, FHA, and PRN). In line with WHO TRS guidelines, we need to ensure that the manufacturing purification steps effectively reduce the impurity levels of tracheal cytotoxin to acceptable levels.